RxDoctor Payments Data

Shannon Barus, APRN

Family · Eureka, KSNPI 1437671476

Payments from drug & device makers

$290in general payments, 2019–2025

Across 16 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$85
  • Lilly USA, LLC$52
  • Pfizer$37
  • AstraZeneca$27
  • Sanofi Pasteur Inc.$24
  • Merck$15
  • plus $50 from 4 others

What the payments were for

  • Food & beverage$290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$290 in reported general payments places this provider in the 50th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$656
Medicare patients
17
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide15$16,387
JardianceEmpagliflozin12$12,702
Tresiba Flextouch U-200Insulin Degludec15$12,488
Arnuity ElliptaFluticasone Furoate11$3,000
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$812
Omeprazole52$745
Gabapentin33$635
FenofibrateFenofibrate Nanocrystallized12$576
Cyclobenzaprine Hcl43$453
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$419
Duloxetine Hcl30$407
Zolpidem Tartrate40$382
Diclofenac Sodium28$356
Atorvastatin Calcium58$355
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$52$16,38715 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$26735 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,579 family providers in Kansas.

Other family in Eureka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →